🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate if the addition of Bortezomib (Vel...
Status
Completed
Location
Istituto Clinico Humanitas
Start Date
2008-02
Trial ID
NCT00636311
Treatments Being Tested
A pilot trial of combination of bortezomib, bevacizumab and carboplatin as ...
Status
Terminated
Location
University of Massachusetts Medical School
Start Date
2006-06
Trial ID
NCT00424840
Note: The study data was transferred to zr pharma\& following the divestmen...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-04-27
Trial ID
NCT02654990
Treatments Being Tested
This is a single-arm, open-label study to evaluate the efficacy and safety ...
Status
Active Not Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2023-05-23
Trial ID
NCT05870917
Treatments Being Tested
This is a randomized multicenter study that will compare two treatment regi...
Status
Active Not Recruiting
Location
University Of Chicago Medicine Comprehensive Cancer Center
Start Date
2019-05-07
Trial ID
NCT03729804
Treatments Being Tested
The purpose of this study is to evaluate safety and effectiveness of CNTO 3...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00911859
The purpose of this study is to: Investigate the Overall Response Rate (ORR...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2010-07
Trial ID
NCT01119794
Treatments Being Tested
Given the disappointing results with routine ASCT in t(4;14) patients, we p...
Status
Completed
Location
Cross Cancer Institute 11560 University Ave
Start Date
2008-08-25
Trial ID
NCT00570180
Treatments Being Tested
Asian patients with relapsed myeloma after prior treatment with bortezomib ...
Status
Unknown
Location
National University Hospital
Start Date
2014-11
Trial ID
NCT02158702
Treatments Being Tested
This phase II trial studies the side effects and how well combination chemo...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-08-09
Trial ID
NCT03136146